Piotr Hadaczek

3.7k total citations
64 papers, 3.0k citations indexed

About

Piotr Hadaczek is a scholar working on Molecular Biology, Genetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Piotr Hadaczek has authored 64 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 28 papers in Genetics and 18 papers in Cellular and Molecular Neuroscience. Recurrent topics in Piotr Hadaczek's work include Virus-based gene therapy research (19 papers), RNA Interference and Gene Delivery (14 papers) and Nerve injury and regeneration (14 papers). Piotr Hadaczek is often cited by papers focused on Virus-based gene therapy research (19 papers), RNA Interference and Gene Delivery (14 papers) and Nerve injury and regeneration (14 papers). Piotr Hadaczek collaborates with scholars based in United States, Poland and Australia. Piotr Hadaczek's co-authors include Krystof S. Bankiewicz, John Forsayeth, John R. Bringas, Adrian P. Kells, Jamie L. Eberling, Teresa Druck, Philip Pivirotto, Howard J. Federoff, Jan Lubiński and Agnieszka Ciesielska and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Journal of Neuroscience.

In The Last Decade

Piotr Hadaczek

63 papers receiving 2.9k citations

Peers

Piotr Hadaczek
Stuart Walbridge United States
H. David Shine United States
Andrew Freese United States
Yazhen Zhu United States
Philip H. Schwartz United States
Gregory A. Cox United States
Piotr Hadaczek
Citations per year, relative to Piotr Hadaczek Piotr Hadaczek (= 1×) peers Alfredo Brusco

Countries citing papers authored by Piotr Hadaczek

Since Specialization
Citations

This map shows the geographic impact of Piotr Hadaczek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Piotr Hadaczek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Piotr Hadaczek more than expected).

Fields of papers citing papers by Piotr Hadaczek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Piotr Hadaczek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Piotr Hadaczek. The network helps show where Piotr Hadaczek may publish in the future.

Co-authorship network of co-authors of Piotr Hadaczek

This figure shows the co-authorship network connecting the top 25 collaborators of Piotr Hadaczek. A scholar is included among the top collaborators of Piotr Hadaczek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Piotr Hadaczek. Piotr Hadaczek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heiss, John D., Abhik Ray‐Chaudhury, David E. Kleiner, et al.. (2024). Persistent GDNF Expression 45 Months after Putaminal Infusion of AAV2‐GDNF in a Patient with Parkinson's Disease. Movement Disorders. 39(8). 1412–1417. 10 indexed citations
2.
Ford, Matthew M., Victor S. Van Laar, Katherine M. Holleran, et al.. (2023). GDNF gene therapy for alcohol use disorder in male non-human primates. Nature Medicine. 29(8). 2030–2040. 12 indexed citations
3.
Samaranch, Lluı́s, Vivek Sudhakar, Jerónimo Jurado‐Arjona, et al.. (2019). Adeno-associated viral vector serotype 9–based gene therapy for Niemann-Pick disease type A. Science Translational Medicine. 11(506). 34 indexed citations
4.
Forsayeth, John & Piotr Hadaczek. (2018). Ganglioside Metabolism and Parkinson's Disease. Frontiers in Neuroscience. 12. 45–45. 23 indexed citations
5.
Samaranch, Lluı́s, Bas Blits, Waldy San Sebastián, et al.. (2017). MR-guided parenchymal delivery of adeno-associated viral vector serotype 5 in non-human primate brain. Gene Therapy. 24(4). 253–261. 61 indexed citations
6.
Soroceanu, Liliana, Lisa Matlaf, Armin Akhavan, et al.. (2015). Cytomegalovirus Immediate-Early Proteins Promote Stemness Properties in Glioblastoma. Cancer Research. 75(15). 3065–3076. 68 indexed citations
7.
Samaranch, Lluı́s, Piotr Hadaczek, Adrian P. Kells, et al.. (2015). Slow AAV2 clearance from the brain of nonhuman primates and anti-capsid immune response. Gene Therapy. 23(4). 393–398. 6 indexed citations
8.
Hadaczek, Piotr, Tomoko Ozawa, Liliana Soroceanu, et al.. (2013). Cidofovir: A Novel Antitumor Agent for Glioblastoma. Clinical Cancer Research. 19(23). 6473–6483. 57 indexed citations
9.
Hadaczek, Piotr, Janine Beyer, Adrian P. Kells, et al.. (2011). Evaluation of an AAV2-Based Rapamycin-Regulated Glial Cell Line-Derived Neurotrophic Factor (GDNF) Expression Vector System. PLoS ONE. 6(11). e27728–e27728. 15 indexed citations
10.
Hadaczek, Piotr, Louisa C. Johnston, John Forsayeth, & Krystof S. Bankiewicz. (2010). Pharmacokinetics and bioactivity of glial cell line-derived factor (GDNF) and neurturin (NTN) infused into the rat brain. Neuropharmacology. 58(7). 1114–1121. 33 indexed citations
11.
Varenika, Vanja, Adrian P. Kells, Francisco Valles, et al.. (2009). Controlled dissemination of AAV vectors in the primate brain. Progress in brain research. 175. 163–172. 26 indexed citations
12.
Johnston, Louisa C., Jamie L. Eberling, Philip Pivirotto, et al.. (2009). Clinically Relevant Effects of Convection-Enhanced Delivery of AAV2-GDNF on the Dopaminergic Nigrostriatal Pathway in Aged Rhesus Monkeys. Human Gene Therapy. 20(5). 497–510. 76 indexed citations
13.
Johnston, Louisa C., Xiaomin Su, Kathleen A. Maguire‐Zeiss, et al.. (2008). Human Interleukin-10 Gene Transfer Is Protective in a Rat Model of Parkinson's Disease. Molecular Therapy. 16(8). 1392–1399. 68 indexed citations
14.
Hadaczek, Piotr, Jacek Gronwald, Maria Chosia, Kay Huebner, & Jan Lubiński. (2001). Fhit protein expression in endometrial cancers: no correlation with histological grade.. PubMed. 52(4). 199–203. 2 indexed citations
15.
Jakubowska, Anna, Tomasz Byrski, Tomasz Huzarski, et al.. (2001). Detection of germline mutations in the BRCA1 gene by RNA-based sequencing. Human Mutation. 18(2). 149–156. 19 indexed citations
16.
Götte, Karl, et al.. (2000). Fhit expression is absent or reduced in a subset of primary head and neck cancer.. PubMed. 20(2A). 1057–60. 11 indexed citations
17.
Hadaczek, Piotr, Zurab Siprashvili, Maciej M. Markiewski, et al.. (1998). Absence or reduction of Fhit expression in most clear cell renal carcinomas.. PubMed. 58(14). 2946–51. 69 indexed citations
18.
Kovatich, Albert J., David Friedland, Teresa Druck, et al.. (1998). Molecular alterations to human chromosome 3p loci in neuroendocrine lung tumors. Cancer. 83(6). 1109–1117. 38 indexed citations
19.
Druck, Teresa, Piotr Hadaczek, T B Fu, et al.. (1997). Structure and expression of the human FHIT gene in normal and tumor cells.. PubMed. 57(3). 504–12. 173 indexed citations
20.
Lubiński, Jan, Stanisław Zajączek, Józef Kładny, et al.. (1996). Hereditary tumors - prophylactics, early diagnosis, treatment. Biotechnologia. 201–207.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026